This study supports the hypothesis that disrupted ESCRT function affects the trafficking of APP and its proteolytic derivatives, such as Aβ, and demonstrates that impairing TSG101-dependent processes leads to rapid-onset neurodegeneration in brain areas impacted in AD. This evidence concerns the gene APP and Alzheimer disease.